The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ferring; Janssen; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Pfizer
Research Funding - Allergan; Astellas Amgen BioPharama; Dendreon; Janssen; Lilly; Merck; Myovant Sciences; Pfizer
A phase III randomized, placebo-controlled, double-blind study of niraparib plus abiraterone acetate and prednisone versus abiraterone acetate and prednisone in patients with metastatic prostate cancer (NCT03748641).
 
Kim N. Chi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; ESSA; Janssen; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
 
Dana E. Rathkopf
Consulting or Advisory Role - AstraZeneca; Genentech; Janssen
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Gerhardt Attard
Honoraria - Astellas Pharma; Janssen; Janssen (I)
Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; AstraZeneca; Bayer; ESSA; Ferring; Janssen-Cilag; Medivation; Millennium; Novartis; Pfizer; Ventana Medical Systems; Veridex
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Ipsen; Janssen; Sanofi; Takeda; Ventana Medical Systems
Research Funding - Arno Therapeutics (Inst); Innocrin Pharma (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - I am on The ICR rewards to inventors list of abiraterone acetate.
Travel, Accommodations, Expenses - Abbott Laboratories; Astellas Pharma; Astellas Pharma (I); Bayer; ESSA; Ferring; Janssen; Janssen (I); Medivation; Pfizer; Ventana Medical Systems
Other Relationship - Institute of Cancer Research
 
Matthew Raymond Smith
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Janssen Oncology; Lilly; Novartis; Pfizer
Research Funding - Bayer (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen; Lilly
 
Eleni Efstathiou
Honoraria - Janssen Research & Development; Sanofi
Consulting or Advisory Role - Janssen Research & Development; ORIC Pharmaceuticals; Sanofi; Tolmar
Speakers' Bureau - Janssen
Research Funding - Astellas Amgen BioPharama (Inst); Janssen Research & Development (Inst); Pfizer (Inst); Sanofi Pasteur (Inst)
Travel, Accommodations, Expenses - Janssen; ORIC Pharmaceuticals; Sanofi
 
David Olmos
Honoraria - Astellas Pharma (Inst); Bayer; Janssen
Consulting or Advisory Role - AstraZeneca (Inst); Bayer; Bayer (Inst); Clovis Oncology; Janssen; Janssen (Inst)
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen
Consulting or Advisory Role - Beigene; Fortis; Janssen Oncology; Tolero Pharmaceuticals
Research Funding - Janssen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Janssen
 
Ji Youl Lee
No Relationships to Disclose
 
Paul R. Sieber
No Relationships to Disclose
 
Curtis Dunshee
Consulting or Advisory Role - Ferring; Genzyme; Pfizer
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Dendreon (Inst); Eleven Biotherapeutics (Inst); Exact Sciences (Inst); Ferring (Inst); Janssen Oncology (Inst); Myovant Sciences (Inst); pfizer (Inst); Siemens (Inst); TesoRX Pharmaceuticals (Inst)
 
Deborah S. Ricci
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Patents, Royalties, Other Intellectual Property - janssen related (Inst); janssen related (Inst)
Travel, Accommodations, Expenses - Janssen
 
Jason S. Simon
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson
 
Xin Zhao
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Nishi Kothari
No Relationships to Disclose
 
Shinta Cheng
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Patents, Royalties, Other Intellectual Property - Patent under Bristol Myers Squibb company (Inst)
 
Shahneen Kaur Sandhu
Honoraria - Amgen; Bristol-Myers Squibb; Merck; Merck Serono
Consulting or Advisory Role - Amgen
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche/Genentech
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Roche/Genentech